Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Nature Communications|July 24, 2019
Regulatory pathways governing murine coronary vessel formation are dysregulated in the injured adult heartSophie Payne, Mala Gunadasa-Rohling, Alice Neal, et al.
Hypertension (Dallas, Tex. : 1979)|May 31, 2018
Endothelial Cell Tetrahydrobiopterin Modulates Sensitivity to Ang (Angiotensin) II-Induced Vascular Remodeling, Blood Pressure, and Abdominal Aortic AneurysmSurawee Chuaiphichai, Victoria S Rashbrook, Ashley B Hale, et al.
JCO Precision Oncology|August 31, 2022
Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and FunctionAfshin Dowlati, Ata Abbas, Timothy Chan, et al.
JAMA Network Open|May 2, 2023
Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With ImmunotherapyCharu Aggarwal, Rotem Ben-Shachar, Yinjie Gao, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Optimization and metabolic stabilization of a class of nonsteroidal glucocorticoid modulatorsJ T Link, Bryan K Sorensen, Jyoti Patel, et al.
Free Radical Biology & Medicine|December 3, 2014
Regulation of iNOS function and cellular redox state by macrophage Gch1 reveals specific requirements for tetrahydrobiopterin in NRF2 activationEileen McNeill, Mark J Crabtree, Natasha Sahgal, et al.
Bioorganic & Medicinal Chemistry|March 15, 2006
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseasesVincent C O Njar, Lalji Gediya, Puranik Purushottamachar, et al.
Cancer|December 13, 2005
Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinomaFaye M Johnson, Lee M Krug, Hai T Tran, et al.
Nitric Oxide : Biology and Chemistry|April 28, 2020
Isolation and culture of murine bone marrow-derived macrophages for nitric oxide and redox biologyJade D Bailey, Andrew Shaw, Eileen McNeill, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2010
Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/IV non-small cell lung cancer: Hoosier Oncology Group LUN06-116Erin M Casey, Wael Harb, Daniel Bradford, et al.
Pageof 8